Cantor Initiates Brooklyn ImmunoTherapeutics Inc (BTX) at Overweight

December 29, 2021 6:10 AM EST Send to a Friend
(Updated - December 29, 2021 6:32 AM EST)Cantor Fitzgerald analyst Kristen Kluska starts coverage on Brooklyn ImmunoTherapeutics Inc (NASDAQ: BTX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login